| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |